Literature DB >> 3092334

Community participation within a primary health care programme.

M Tanner, G K Lwihula, E Burnier, D De Savigny, A Degrémont.   

Abstract

Based on experiences made in rural communities of Tanzania, aspects of community participation in schistosomiasis control within a primary health care (PHC) programme are discussed. Community participation is seen as prerequisite for PHC. Building up community participation can not be disease- or even symptom-orientated, it must be community problem-orientated. The assessment of village priorities as they are recognized by the community governs any control strategy based on PHC. As schistosomiasis is often not first ranking among community problems, schistosomiasis control must become part of a multisectorial approach to improve community health. This process can initiate and ensure community participation and may lead to cost-effective control measures within PHC.

Entities:  

Mesh:

Year:  1986        PMID: 3092334

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  3 in total

1.  Community participation for malaria elimination in Tafea Province, Vanuatu: Part I. Maintaining motivation for prevention practices in the context of disappearing disease.

Authors:  Jo-An M Atkinson; Lisa Fitzgerald; Hilson Toaliu; George Taleo; Anna Tynan; Maxine Whittaker; Ian Riley; Andrew Vallely
Journal:  Malar J       Date:  2010-04-12       Impact factor: 2.979

2.  Health seeking behaviour and utilization of health facilities for schistosomiasis-related symptoms in ghana.

Authors:  Anthony Danso-Appiah; Wilma A Stolk; Kwabena M Bosompem; Joseph Otchere; Caspar W N Looman; J Dik F Habbema; Sake J de Vlas
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

3.  Lack of effective communication between communities and hospitals in Uganda: a qualitative exploration of missing links.

Authors:  Elizeus Rutebemberwa; Elizabeth Ekirapa-Kiracho; Olico Okui; Damien Walker; Aloysius Mutebi; George Pariyo
Journal:  BMC Health Serv Res       Date:  2009-08-12       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.